J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 26,372 shares at $19.54 ($513K) on 2019-05-16, disclosed to the SEC on 2019-05-17.
Open-market sale of $513k FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.46 | 2,298 | $42K | 8.3% |
| 2 | $19.54 | 12,037 | $235K | 45.9% |
| 3 | $19.54 | 12,037 | $235K | 45.9% |
| Total | $19.45 avg | 26,372 | $513K | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |